688221 前沿生物
按盤價 
22.740 +3.790 (+20.000%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 22.910 | -26.564 | -16.214 | -21.828 | -20.377 |
| 總資產報酬率 ROA (%) | 13.264 | -15.812 | -10.191 | -14.457 | -14.434 |
| 投入資產回報率 ROIC (%) | 14.308 | -17.132 | -11.013 | -15.867 | -15.742 | 邊際利潤分析 |
| 銷售毛利率 (%) | 94.006 | 33.218 | 33.927 | 28.995 | 18.605 |
| 營業利潤率 (%) | 76.614 | -216.977 | -155.317 | -286.857 | -421.616 |
| 息稅前利潤/營業總收入 (%) | 76.593 | -217.320 | -149.998 | -281.255 | -421.061 |
| 淨利潤/營業總收入 (%) | 76.530 | -217.246 | -155.540 | -287.935 | -421.008 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.852 | 95.314 | 137.158 | 106.828 | 111.148 |
| 價值變動淨收益/利潤總額(%) | 1.740 | 0.601 | -41.799 | -5.065 | -5.590 |
| 營業外收支淨額/利潤總額(%) | -0.111 | 0.124 | 0.144 | 0.374 | -0.144 | 償債能力分析 |
| 流動比率 (X) | 3.540 | 2.449 | 3.094 | 2.901 | 5.072 |
| 速動比率 (X) | 3.325 | 2.286 | 2.990 | 2.746 | 4.871 |
| 資產負債率 (%) | 40.108 | 44.443 | 37.019 | 37.262 | 30.670 |
| 帶息債務/全部投入資本 (%) | 24.548 | 24.475 | 20.972 | 14.050 | 7.587 |
| 股東權益/帶息債務 (%) | 259.210 | 249.359 | 321.530 | 486.436 | 1,009.651 |
| 股東權益/負債合計 (%) | 149.329 | 125.010 | 170.135 | 168.373 | 226.052 |
| 利息保障倍數 (X) | 1,214.123 | 2,940.865 | -27.062 | -42.107 | 7,917.325 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 14.671 | 136.027 | 135.910 | 156.202 | 124.219 |
| 存貨周轉天數 (天) | 365.926 | 235.226 | 210.543 | 254.308 | 245.900 |
| 備註： | 即時報價更新時間為 27/04/2026 15:28 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
